Financhill
Back

Arcellx Quote, Financials, Valuation and Earnings

Arcellx Price Quote

$75.42
-0.21 (0.28%)
(Updated: December 21, 2024 at 5:13 AM ET)

Arcellx Key Stats

Sell
14
Arcellx (ACLX) is a Sell

Day range:
$73.40 - $76.41
52-week range:
$47.88 - $107.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
25.36
P/B ratio:
8.47%

Volume:
1.3M
Avg. volume:
590.7K
1-year change:
49.29%
Market cap:
$4.1B
Revenue:
$110.3M
EPS:
$-0.71

How Much Does Arcellx Make?

Data Unavailable

Is Arcellx Growing As A Company?

Data Unavailable

Arcellx Stock Price Performance

  • Did Arcellx Stock Go Up Last Month?
    Arcellx share price went down by -13.29% last month
  • Did ACLX's Share Price Rise Over The Last Year?
    ACLX share price rose by 49.29% over the past 1 year

What Is Arcellx 52-Week High & Low?

  • What Is Arcellx’s 52-Week High Share Price?
    Arcellx has traded as high as $107.37 over the past 52 weeks
  • What Is Arcellx’s 52-Week Low Share Price?
    Arcellx has traded as low as $47.88 over the past 52 weeks

Arcellx Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcellx?

Data Unavailable

Is Arcellx Cash Flow Positive?

Data Unavailable

Arcellx Return On Invested Capital

Data Unavailable

Arcellx Earnings Date & Stock Price

  • What Is Arcellx's Stock Price Today?
    A single share of ACLX can be purchased today for 75.63
  • What Is Arcellx’s Stock Symbol?
    Arcellx trades on the nasdaq under the ticker symbol: ACLX
  • When Is Arcellx’s Next Earnings Date?
    The next quarterly earnings date for Arcellx is scheduled on March 28, 2025
  • When Is ACLX's next ex-dividend date?
    Arcellx's next ex-dividend date is December 21, 2024
  • How To Buy Arcellx Stock?
    You can buy Arcellx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Arcellx Competitors

  • Who Are Arcellx's Competitors?
    Below is a list of companies who compete with Arcellx or are related in some way:
    • AbbVie Inc (ABBV)
    • Agios Pharmaceuticals Inc (AGIO)
    • Boston Scientific Corp (BSX)
    • Gilead Sciences Inc (GILD)
    • Johnson & Johnson (JNJ)

Arcellx Dividend Yield

Data Unavailable

Arcellx Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -96.2%
Revenue: 74.03% -32.76%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 116.38
Upside from Last Price: 53.87%

Major Shareholders

Data Unavailable